Absent or hypoplastic nasal bone: What to tell the prospective parents?
Birth Defects Research · 2024
DOI: 10.1002/bdr2.2348 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Birth Defects Research, 2024. Verfasst von Shreya Das und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics & Gynecology, All India Institute of Medical Sciences, Jodhpur, India. Hauptthemen laut MEDLINE: Nasal Bone, Down Syndrome, Ultrasonography, Prenatal. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 40 Literaturangaben.
Abstract (Originalsprache)
Background
Absent or hypoplastic nasal bone (AHNB) on first or second‐trimester ultrasonography (USG) is an important soft marker of Down syndrome. However, due to its varied incidence in euploid and aneuploid fetuses, there is always a dilemma of whether to go for invasive fetal testing for isolated AHNB. This study aims to assess outcomes specifically within the context of Indian ethnicity women. Materials and Methods This was a prospective observational study. All patients who reported with AHNB in the first‐ or second‐trimester USG were included. Genetic counseling was done, and noninvasive and invasive testing was offered. Chromosomal anomalies were meticulously recorded, and pregnancy was monitored.
Results
The incidence of AHNB in our study was 1.16% (47/4051). Out of 47 women with AHNB, the isolated condition was seen in 32 (0.78%) cases, while AHNB with structural anomalies was seen in nine cases (0.22%). Thirty‐nine women opted for invasive testing. Six out of 47 had aneuploidy (12.7%), while two euploid cases (4.25%) developed nonimmune hydrops. The prevalence of Down syndrome in fetuses with AHNB was 8.5% (4/47) and 0.42% (17/4004) in fetuses with nasal bone present. This difference was statistically significant ( p = .001).
Conclusion
The results indicate that isolated AHNB cases should be followed by a comprehensive anomaly scan rather than immediately recommending invasive testing. However, invasive testing is required when AHNB is associated with other soft markers or abnormalities. As chromosomal microarray is more sensitive than standard karyotype in detecting chromosomal aberrations, it should be chosen over karyotype.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics & Gynecology, All India Institute of Medical Sciences, Jodhpur, India.
- Department of Diagnostic and Interventional Radiology, All India Institute of Medical Sciences, Jodhpur, India.
- Department of Pediatrics, All India Institute of Medical Sciences, Jodhpur, India.
ORCID-Profile: Shreya Das, Charu Sharma, Kalika Dubey, Shashank Shekhar, Pratibha Singh, Kuldeep Singh, Meenakshi Gothwal, Manisha Jhirwal, Dolat Singh Shekhawat
Zitieren
APA
Das, S., Sharma, C., Yadav, T., Dubey, K., Shekhar, S., Singh, P., Singh, K., Gothwal, M., Jhirwal, M., & Shekhawat, D. S. (2024). Absent or hypoplastic nasal bone: What to tell the prospective parents?. Birth Defects Research. https://doi.org/10.1002/bdr2.2348
Vancouver
Das S, Sharma C, Yadav T, Dubey K, Shekhar S, Singh P, et al. Absent or hypoplastic nasal bone: What to tell the prospective parents?. Birth Defects Research. 2024. doi:10.1002/bdr2.2348
BibTeX
@article{Das2024,
author = {Das, Shreya and Sharma, Charu and Yadav, Taruna and Dubey, Kalika and Shekhar, Shashank and Singh, Pratibha and Singh, Kuldeep and Gothwal, Meenakshi and Jhirwal, Manisha and Shekhawat, Dolat Singh},
title = {Absent or hypoplastic nasal bone: What to tell the prospective parents?},
journal = {Birth Defects Research},
year = {2024},
doi = {10.1002/bdr2.2348}
}
EUVIMED